After-Care Information

This page is designed to help you understand what is normal following your treatment, what to monitor, and when to seek additional care. If you have any concerns about your IV or injection site, contact us directly. For all other health concerns, please contact your family physician or a walk-in clinic. In an emergency, call 911 immediately.

Your Treatment Site: What Is Normal

Symptom Overview ✓ What Is Normal ⚠ Contact Us If
Bruising Common and not a cause for concern. Occurs when a small amount of blood leaks into surrounding tissue during or after needle insertion. Does not indicate incorrect technique.

Why bruising varies: Thin veins, blood thinners, anti-inflammatories, Vitamin C or K deficiency, age, and individual clotting differences all affect bruising.

No bruise at all? Simply means the vein sealed well. Not an indicator of quality either way.
  • Mild to moderate bruising appearing within hours
  • Tenderness to touch initially
  • Colour change from purple/red to yellow/green over several days
  • Full resolution within 5 to 10 days
  • Bruising expanding significantly beyond the initial site
  • Increasing pain, heat, or firmness under the skin
  • Bruising not beginning to resolve after 10 days
Discomfort and Pain Mild discomfort during and immediately after treatment is expected. IV therapy involves cannula insertion into a vein; IM injections deliver fluid directly into muscle tissue.
  • Brief sharp sensation during needle insertion
  • Mild aching or pressure at the site during IV infusion
  • Muscle soreness at IM site lasting 24 to 48 hours
  • Tenderness when pressing on site for a day or two
  • Pain worsening rather than improving after 24 hours
  • Significant pain spreading beyond the treatment site
  • Pain with intensifying swelling, redness, or heat
Redness and Warmth A small amount of redness and warmth immediately surrounding the treatment site is a normal inflammatory response to needle insertion and resolves quickly in most cases.
  • Mild redness at the site immediately following treatment
  • Slight warmth to touch resolving within a few hours
  • Small raised area at IM site flattening within 24 hours
  • Redness spreading outward in a streaking pattern
  • Increasing warmth, swelling, and pain beyond 24 hours
  • Skin that appears shiny, tight, or blistered
Discharge No discharge should be present at a properly healed IV or IM site.
  • A very small amount of clear fluid or single drop of blood immediately after needle removal, resolving with brief pressure
  • Any discharge appearing hours after treatment
  • Yellow, green, or cloudy discharge of any amount
  • Discharge accompanied by odour, pain, or surrounding redness

Treatment Ingredient Symptom Profiles

The following outlines commonly reported symptoms associated with specific ingredients used in IV and IM therapies. These are evidence-informed profiles based on known pharmacological and physiological responses.

Ingredient ✓ Normal Responses ⚠ Not Expected -- Contact Your Physician ⓘ Additional Notes
B Complex Vitamins
(B1, B2, B3, B5, B6, B12)
  • Warm or flushed sensation during infusion, especially with B3 (Niacin); a well-documented vasodilatory response resolving within minutes to an hour
  • Bright yellow or fluorescent urine, caused by B2 (Riboflavin) excretion; completely harmless
  • Mild metallic taste during IV infusion
  • General sensation of warmth throughout the body
  • Severe flushing, hives, or rash
  • Difficulty breathing or throat tightness
  • Nausea or vomiting persisting beyond a few hours
Yellow urine is expected and harmless. If you are concerned, it will resolve within 24 hours.
Vitamin C
(Ascorbic Acid)
  • Mild cooling sensation at IV site due to solution temperature
  • Temporary fatigue following high-dose infusions
  • Increased urination in the hours following treatment
  • Significant abdominal cramping or diarrhoea
  • Any symptoms in individuals with a history of oxalate kidney stones. Contact us if this was not discussed at screening
Kidney stone history is a relative contraindication and should have been identified at screening.
Magnesium
  • Sensation of warmth or flushing throughout the body during infusion
  • Feeling of heaviness or deep muscle relaxation
  • Mild lightheadedness or floaty sensation during infusion
  • Brief dizziness from temporary blood pressure drop
  • Fatigue or drowsiness following treatment, sometimes for several hours
  • Prolonged dizziness or faintness after treatment ends
  • Nausea or vomiting
  • Muscle weakness persisting beyond the day of treatment
This is one of the most commonly felt ingredients. Remaining seated or lying down during treatment is recommended for this reason.
Zinc
  • Metallic or unpleasant taste during IV infusion, well documented and temporary
  • Mild nausea during infusion, particularly if administered quickly
  • Persistent nausea beyond the infusion period
  • Vomiting
The metallic taste is expected and resolves immediately after infusion ends.
B12
(Methylcobalamin or Cyanocobalamin)
IM Injection
  • Mild stinging or burning at the injection site during administration
  • Localised soreness lasting 24 to 48 hours
  • Mild energy increase or, conversely, fatigue, both are reported
  • Significant swelling or hardness at the site persisting beyond 48 hours
  • Rash, itching, or hives
Soreness similar to post-vaccine injection is expected and resolves within 48 hours.
Vitamin D3
IM Injection
  • Mild localised soreness at the injection site for 24 to 48 hours
  • Occasional mild fatigue in the days following a loading dose
  • Persistent nausea, vomiting, weakness, or confusion in the days following treatment. Contact your physician as these can indicate Vitamin D toxicity, though this is extremely unlikely from a single therapeutic dose
Toxicity from a single therapeutic injection is extremely unlikely.
Glutathione
IV or IM
  • Mild garlic-like taste or smell during or shortly after IV administration, caused by sulphur-containing compounds; harmless and temporary
  • Mild skin flushing in some individuals
  • IM injection site soreness for 24 to 48 hours
  • Significant rash or hives
  • Difficulty breathing, seek emergency care immediately
If you have clinical questions about your Glutathione treatment, you can request a telehealth consult with our supervising nurse practitioner through your client portal.
NAD+
(Nicotinamide Adenine Dinucleotide)
  • Chest tightness or pressure sensation, the most commonly reported NAD+ symptom; not cardiac in origin when it resolves with rate reduction
  • Nausea, sometimes significant
  • Abdominal cramping
  • Flushing and warmth
  • Muscle aching or cramping, particularly in the legs
  • Headache
  • Anxiety or restlessness
  • Fatigue during and after infusion
  • Chest pain that does not resolve after infusion ends, seek emergency care immediately
  • Difficulty breathing at any point, seek emergency care immediately
  • Any of the above symptoms persisting after infusion has ended, contact your physician
NAD+ is rate-sensitive. All listed normal responses are manageable by slowing the infusion rate and do not typically persist beyond the infusion period. NAD+ infusions are administered slowly and monitored closely for this reason.
Toradol
(Ketorolac)
IV or IM
  • Mild burning sensation at the site during administration
  • Drowsiness in some individuals
  • Stomach discomfort can still occur
  • Relief often begins within 10 to 30 minutes, with full effect building over the next couple of hours
  • Stomach pain worsening rather than improving after treatment
  • Dark or tarry stools in the days following treatment, this can indicate gastrointestinal bleeding and requires prompt medical attention
  • Decreased urine output or leg swelling, as Toradol can affect kidney function in susceptible individuals
Post-treatment instructions:
  • Avoid alcohol for 24 hours
  • Do not take ibuprofen, naproxen, aspirin, or other anti-inflammatories within 24 hours unless specifically advised by a physician or nurse practitioner
  • Stay well hydrated
Gravol
(Dimenhydrinate)
IV or IM
  • Drowsiness, the most common and expected effect; may last several hours
  • Dry mouth
  • Mild grogginess or difficulty concentrating
  • Feeling of relaxation or sedation
  • Significant confusion or disorientation beyond mild grogginess
  • Difficulty urinating
  • Rapid or irregular heartbeat
Post-treatment instructions:
  • Do not drive or operate machinery until drowsiness has fully resolved
  • Avoid alcohol on the day of treatment as it enhances the sedative effect

🛑 When to Call 911 or Go to Emergency

The following symptoms are uncommon but require immediate emergency care. Do not wait to contact us first.

  • Difficulty breathing or shortness of breath
  • Throat tightness or swelling of the face, lips, or tongue
  • Chest pain that does not resolve
  • Rapid or irregular heartbeat
  • Sudden severe headache, confusion, or loss of consciousness
  • Hives, widespread rash, or signs of a severe allergic reaction

Call 911 immediately.

Contact

For concerns about your IV or injection site, contact us at:

Phone: 778-762-1962
Email: [email protected]
Website: www.hyndfordhydration.ca

If you have clinical questions related to your treatment and would prefer to speak with our supervising nurse practitioner, you can request a telehealth consult directly through your client portal. Please note that telehealth consults are subject to NP availability and are not an emergency service.

For all other health concerns following your treatment, please contact your family physician or a local walk-in clinic.

This information is intended as general after-care guidance following treatment at Hyndford Hydration. It does not replace individualized medical advice. Always err on the side of caution and contact a healthcare professional when unsure.